Drug Management in End-of-Life Hospitalized Palliative Care Cancer Patients: The RHESO Cohort Study
Conclusions: NACT prescription remained commonplace in terminally ill palliative cancer patients, although their benefit is questionable.Oncology
Source: Oncology - Category: Cancer & Oncology Source Type: research
More News: Brain | Brain Cancers | Cancer | Cancer & Oncology | Corticosteroid Therapy | France Health | Hemorrhagic Stroke | Morphine | Neurology | Palliative | Palliative Care | Study | Thrombosis